Article (Scientific journals)
Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L/L promoter variants.
Adamsen, Dea; Meili, David; Blau, Nenad et al.
2011In Molecular Genetics and Metabolism, 102 (3), p. 368-73
Peer Reviewed verified by ORBi
 

Files


Full Text
RAMAEKERS V (MOL GEN METAB 2011, 368).pdf
Publisher postprint (534.19 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
5-Hydroxytryptophan/therapeutic use; Amino Acid Substitution; Antidepressive Agents, Second-Generation/therapeutic use; Autistic Disorder/drug therapy/genetics/metabolism; Child, Preschool; Genotype; Humans; Hydroxyindoleacetic Acid/cerebrospinal fluid; Male; Mutation; Polymorphism, Genetic; Promoter Regions, Genetic/genetics; Serotonin/metabolism; Serotonin Plasma Membrane Transport Proteins/genetics/metabolism; Treatment Outcome
Abstract :
[en] The known Gly56Ala mutation in the serotonin transporter SERT (or 5-HTT), encoded by the SLC6A4 gene, causes increased serotonin reuptake and has been associated with autism and rigid-compulsive behavior. We report a patient with macrocephaly from birth, followed by hypotonia, developmental delay, ataxia and a diagnosis of atypical autism (PDD-NOS) in retrospect at the age of 4(1/2)years. Low levels of the serotonin end-metabolite 5-hydroxyindolacetic acid (5HIAA) in CSF were detected, and SLC6A4 gene analysis revealed the heterozygous Gly56Ala alteration and the homozygous 5-HTTLPR L/L promoter variant. These changes are reported to be responsible for elevated SERT activity and expression, suggesting that these alterations were responsible in our patient for low serotonin turnover in the central nervous system (CNS). Daily treatment with 5-hydroxytryptophan (and carbidopa) led to clinical improvement and normalization of 5HIAA, implying that brain serotonin turnover normalized. We speculate that the mutated 56Ala SERT transporter with elevated expression and basal activity for serotonin re-uptake is accompanied with serotonin accumulation within pre-synaptic axons and their vesicles in the CNS, resulting in a steady-state of lowered serotonin turnover and degradation by monoamine-oxidase (MAO) enzymes in pre-synaptic or neighboring cells.
Disciplines :
Neurology
Author, co-author :
Adamsen, Dea
Meili, David
Blau, Nenad
Thony, Beat
RAMAEKERS, Vincent ;  Centre Hospitalier Universitaire de Liège - CHU > Pédiatrie
Language :
English
Title :
Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L/L promoter variants.
Publication date :
2011
Journal title :
Molecular Genetics and Metabolism
ISSN :
1096-7192
eISSN :
1096-7206
Publisher :
Academic Press
Volume :
102
Issue :
3
Pages :
368-73
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
SNSF - Swiss National Science Foundation [CH]
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Novartis [BE]
Centre for neuroscience Zürich
Commentary :
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Available on ORBi :
since 02 February 2012

Statistics


Number of views
187 (4 by ULiège)
Number of downloads
446 (1 by ULiège)

Scopus citations®
 
22
Scopus citations®
without self-citations
21
OpenCitations
 
19

Bibliography


Similar publications



Contact ORBi